PDE4D and Alzheimer disease: Our study suggested that the levels of these two proteins were significantly decreased in Aβ1–42-treated mice, but PDE4D deficiency in the prefrontal cortex increased the expression of synaptophysin and PSD-95, indicating the role of PDE4D inhibition in amelioration of synaptic plasticity and neuronal atrophy in the progression of AD.